MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,393,289 | +39.0% | 881,226 | +15.3% | 0.01% | +66.7% |
| Q2 2023 | $27,620,782 | +1.0% | 764,483 | +4.0% | 0.00% | -25.0% |
| Q1 2023 | $27,338,020 | +85200.7% | 735,288 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $32,049 | -99.9% | 707,345 | +7.8% | 0.00% | -42.9% |
| Q3 2022 | $45,811,000 | +5.5% | 655,950 | +1.4% | 0.01% | +16.7% |
| Q2 2022 | $43,436,000 | -17.2% | 647,050 | +1.4% | 0.01% | -14.3% |
| Q1 2022 | $52,483,000 | -41.9% | 638,329 | +3.6% | 0.01% | -36.4% |
| Q4 2021 | $90,354,000 | -8.9% | 615,953 | +9.8% | 0.01% | -15.4% |
| Q3 2021 | $99,219,000 | +7.9% | 560,849 | -1.5% | 0.01% | 0.0% |
| Q2 2021 | $91,939,000 | -28.9% | 569,179 | -24.6% | 0.01% | -35.0% |
| Q1 2021 | $129,269,000 | -15.8% | 754,636 | +8.0% | 0.02% | -23.1% |
| Q4 2020 | $153,469,000 | +60.7% | 698,735 | +21.5% | 0.03% | +36.8% |
| Q3 2020 | $95,512,000 | +46.4% | 575,202 | +0.7% | 0.02% | +35.7% |
| Q2 2020 | $65,236,000 | +66.7% | 571,399 | +12.2% | 0.01% | +40.0% |
| Q1 2020 | $39,130,000 | -65.6% | 509,054 | -42.3% | 0.01% | -16.7% |
| Q4 2019 | $113,780,000 | +239.5% | 882,986 | +105.3% | 0.01% | +50.0% |
| Q3 2019 | $33,510,000 | -21.2% | 430,124 | +4.2% | 0.01% | -20.0% |
| Q2 2019 | $42,518,000 | +56.1% | 412,801 | +11.1% | 0.01% | +42.9% |
| Q1 2019 | $27,245,000 | +2.2% | 371,703 | -40.9% | 0.01% | +75.0% |
| Q4 2018 | $26,656,000 | +95.9% | 628,436 | +117.5% | 0.00% | 0.0% |
| Q3 2018 | $13,608,000 | +1.6% | 288,925 | +6.3% | 0.00% | 0.0% |
| Q2 2018 | $13,396,000 | +136.6% | 271,743 | +47.4% | 0.00% | +100.0% |
| Q1 2018 | $5,661,000 | +68.2% | 184,406 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $3,365,000 | +69.5% | 184,406 | +8.7% | 0.00% | 0.0% |
| Q3 2017 | $1,985,000 | +433.6% | 169,685 | +66.3% | 0.00% | – |
| Q2 2017 | $372,000 | -39.8% | 102,064 | -14.2% | 0.00% | – |
| Q1 2017 | $618,000 | +19.3% | 118,988 | +8.9% | 0.00% | – |
| Q4 2016 | $518,000 | -26.6% | 109,262 | +2.2% | 0.00% | – |
| Q3 2016 | $706,000 | +17.9% | 106,922 | -2.7% | 0.00% | – |
| Q2 2016 | $599,000 | -72.6% | 109,839 | +7.6% | 0.00% | -100.0% |
| Q1 2016 | $2,185,000 | -33.9% | 102,128 | -2.4% | 0.00% | -50.0% |
| Q4 2015 | $3,306,000 | +2.7% | 104,648 | +11.9% | 0.00% | 0.0% |
| Q3 2015 | $3,218,000 | +668.0% | 93,500 | +600.8% | 0.00% | – |
| Q2 2015 | $419,000 | +20.1% | 13,341 | +11.9% | 0.00% | – |
| Q1 2015 | $349,000 | – | 11,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |